2 ASX 200 healthcare shares to watch in August

Here we take a look at why I think these 2 ASX 200 healthcare shares, Nanosonics and Fisher & Paykel, are ones to watch during August.

| More on:
digitised image of line chart together with covid bugs signifying asx 200 healthcare shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare shares have been a major benefactor of the COVID-19 pandemic. While the containment of COVID-19 cases continues to be a challenge around the globe, here are two ASX 200 healthcare shares to watch closely in August. 

2 ASX 200 healthcare shares I'm watching closely

1. Nanosonics Ltd (ASX: NAN

There could be some nerves around Nanosonics' FY20 full year results that are due later this month. The last market sensitive announcement from the company was its business update back in early April. This business update highlighted that unaudited sales for Q3 FY20 were significantly up on the prior corresponding period (pcp) and sales of consumables were in line with the company's pre-COVID-19 expectations. However, limited direct access to hospitals may extend the time needed for hospital departments to adopt the company's ultrasound disinfection products. This may result in lower than anticipated overall growth for its installed base in Q4 and therefore FY20.

I believe in today's COVID-19 world, where there is a heightened focus on hygiene, Nanosonics plays an ever important role in the disinfection of ultrasound probes. However, mobility restrictions are likely to impact its ability to further penetrate new markets across Europe, the Middle East and Asia Pacific. Notwithstanding the inherent risks in its FY20 result, Nanosonics is a leading ASX 200 healthcare share to watch closely this earnings season.

2. Fisher & Paykel Healthcare Corp Ltd (ASX: FPH

The Fisher & Paykel share price has soared more than 50% this year following COVID-19 tailwinds for its business. August, however, had appeared to be a challenging month for the company with its shares tumbling 10% from the all-time record highs set in July. This was the case until the business provided an upbeat FY21 trading update on Tuesday that saw the Fisher & Paykel share price jump by 4%. 

This trading update highlighted strong demand for the company's hospital respiratory care products. Managing Director and CEO, Lewis Gradon, said that "Hospital hardware sales have continued to steadily increase over the first four months of FY21 with +390% constant currency revenue growth to the end of July compared to pcp". He also noted that "Global sales of both invasive ventilation and Optiflow consumables in July have returned to similar levels to the peak we saw in April". The company is seeing that revenue by geography tends to follow the incidence of COVID-19 cases.

Fisher & Paykel estimates that FY21 operating revenue will be approximately $1.61 billion and net profit after tax will be approximately $365 million to $385 million (or an increase of 27-34% on FY20). I believe the company is delivering phenomenal growth figures for a large cap ASX 200 healthcare share. While its share price has pushed to extraordinary highs, I would be watching closely for a pullback buying opportunity. 

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Shares to Watch

asx share price rebound represented by wooden blocks spelling rebound with coins on top
⏸️ Shares to Watch

Could the Zip (ASX:Z1P) share price make a comeback in 2021? 

The Zip (ASX: Z1P) share price struggled to outperform in the second half of 2020. Could 2021 be a better…

Read more »

⏸️ Shares to Watch

What next for the a2 Milk (ASX:A2M) share price?

Could you call the A2 Milk Company Ltd (ASX: A2M) share price a cheap growth stock after it slumped to…

Read more »

⏸️ Shares to Watch

What's in store for the Afterpay (ASX:APT) share price in 2021? 

The Afterpay (ASX: APT) share price has surged more than 275% in 2020. Here's a little of what investors can…

Read more »

wondering about asx share price represented by man surrounded by question marks
⏸️ Shares to Watch

Is the Zip (ASX:Z1P) share price a buy yet?

The Zip Co Ltd (ASX: Z1P) share price continues to underperform despite an exciting capital raising. Could it finally be…

Read more »

questioning whether asx share price is a buy represented by man in red shirt scratching his head
⏸️ Shares to Watch

Should you buy the Appen (ASX:APX) share price dip?

Could the Appen Ltd (ASX: APX) share price be a buying opportunity after its recent selloff? We take a look…

Read more »

Share Fallers

Why this broker thinks it's time to buy Qantas (ASX:QAN) shares

As state borders re-open to domestic tourism, this broker thinks it could be time to start buying Qantas Airways Limited…

Read more »

wondering about asx share price represented by man surrounded by question marks
⏸️ Shares to Watch

Could this be why the Zip (ASX:Z1P) share price is underperforming?

Could this be why the Zip Co Ltd (ASX: Z1P) share price is down 50% from its August highs and…

Read more »

Hands grabbing for high rung on a ladder pointing to the sky
⏸️ Shares to Watch

The Rhipe (ASX:RHP) share price has jumped 8% today. Here's why.

The Rhipe Ltd (ASX: RHP) share price has popped 8.59% after announcing its first quarter FY21 update. Here's the run…

Read more »